269. Pyogenic arthritis Clinical trials / Disease details
Clinical trials : 23 / Drugs : 30 - (DrugBank : 12) / Drug target genes : 15 - Drug target pathways : 106
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05120726 (ClinicalTrials.gov) | June 2, 2021 | 11/9/2021 | A Novel Therapeutic Treatment of Pyoderma Gangrenosum | A Novel Therapeutic Treatment of Pyoderma Gangrenosum | Pyoderma Gangrenosum | Biological: Dehydrated human amnion/chorion membrane | Louisiana State University Health Sciences Center in New Orleans | NULL | Recruiting | 18 Years | N/A | All | 20 | Phase 4 | United States |